E734-2697 Screening compound: ethyl 4-[4-({5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate

E734-2697 Screening compound: ethyl 4-[4-({5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate
E734-2697 Screening compound: ethyl 4-[4-({5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound E734-2697
ethyl 4-[4-({5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E734-2697

Molecular Formula

C23H19N3O6S (C23 H19 N3 O6 S)

Compound Name

ethyl 4-[4-({5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate

IUPAC name

ethyl 4-[4-({57-dioxo-5H6H7H-pyrrolo[34-b]pyridin-6-yl}methyl)benzenesulfonamido]benzoate

SMILES

CCOC(c(cc1)ccc1NS(c1ccc(CN(C(c2c3nccc2)=O)C3=O)cc1)(=O)=O)=O

InChI

InChI=1S/C23H19N3O6S/c1-2-32-23(29)16-7-9-17(10-8-16)25-33(30,31)18-11-5-15(6-12-18)14-26-21(27)19-4-3-13-24-20(19)22(26)28/h3-13,25H,2,14H2,1H3

InChI Key

KJMIBAWKSBNMES-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14913834

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.49

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.620

Distribution Coefficient, logD

2.157

Water Solubility, LogSw

-3.19

Polar Surface Area

100.804

Acid Dissociation Constant (pKa)

7.12

Base Dissociation Constant (pKb)

-6.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

E734-2697 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Digestive system
  • Nervous system
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E734-2697 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E734-2697?
Check Price and Availability of E734-2697, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E734-2697 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E734-2697
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E734-2697
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E734-2697 available by request